Emil D. Kakkis: key facts
- Kind of voice
- Sector leader
- Role
- Chief Executive Officer and President, Ultragenyx
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 29 Sept 2026
“This is a historic milestone for a community that has waited far too long, but has never given up hope.”
Where Emil D. Kakkis has been quoted
- Ultragenyx sets $3.95m list price for fatal rare disease therapyemjreviews.com · 29 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
- Delhi University initiates financial assistance for faculty member’s child with rare genetic disorderThe Times of India
- 11% Undervalued? Vertex Pharmaceuticals (VRTX) Following New ALYFTREK DataSimply Wall Street
- DU's SOL steps in to support treatment of faculty member's child with rare genetic disorder | Latest News DelhiHindustan Times
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.